Gene therapy opens new possibilities for treating chronic pain
5 October 2023
Our researchers have shown the potential of a new gene therapy approach to silence human sensory neurons as a means of treating persistent pain. Many current drugs for chronic pain are highly addictive, which makes it important to discover new alternatives.
Six New Professors
8 September 2023
Many congratulations to the following members of our Department who have been awarded the title of Professor in the recent Recognition of Distinction round.
PAINCAST: A new collaborative podcast exploring the experience of neuropathic pain
7 September 2023
PAINCAST: Neuropathic Pain Unravelled, a creative podcast about living with long-term pain, is part of a ground-breaking four-year collaborative research project into neuropathic pain.
Understanding the immune response in people with myasthenia gravis
5 September 2023
Muscular Dystrophy UK has announced that it is investing £1.3 million into 11 new research projects including one at the University of Oxford.
Brief sleep therapy delivered by nurses improves insomnia
11 August 2023
Researchers from the University of Oxford have found that a brief form of cognitive behavioural therapy (CBT) for insomnia, delivered by nurses in GP surgeries, significantly improves sleep and quality of life compared to sleep hygiene alone.
OxSTaR team wins national teaching award
3 August 2023
The work of Oxford University's Oxford Simulation, Teaching and Research team (OxSTaR) has been recognised by a Collaborative Award for Teaching Excellence (CATE).
NDCN groups gain LEAF accreditation for sustainable research
14 July 2023
Several of our research groups have been accredited by the Laboratory Efficiency Assessment Framework (LEAF).
Sir Roger Bannister Prize Winners 2023
14 July 2023
Award Clinical Neurology Teaching
Congratulations to Desson Au-Yeung and George Shaw for their success in this year's competition.
New imaging method trialled for retinal diseases
28 June 2023
Clinical scientists in Oxford have presented a new method of imaging of the retina that overcomes many of the drawbacks of the current standard way of diagnosing and monitoring retinal diseases like age-related macular degeneration (AMD).
Body’s immune response may offer alternative approach to neuropathic pain therapies
28 June 2023
In the midst of a global opioid epidemic, a team of scientists is exploring natural killer (NK) cells as an alternative treatment for neuropathic pain.
Neuroimmunology at Freeland School Science Day
26 June 2023
Clinical Neurology Public engagement
The Davies and Rinaldi laboratories led 'glitter-essence imaging', a craft-based engagement activity at Freeland Primary School Science Day on 17 March 2023 for Brain Awareness Week.
Local young artists recognised in the University of Oxford's science-inspired art competition
26 June 2023
Oxford University has announced the winners of Beyond Boundaries, its science-inspired schools’ art competition. Their work will be going on public display at Oxford University Museum of Natural History for all to see, from Friday 30 June – Monday 3 July 2023.
Thomas Willis Day 2023
23 June 2023
This is an annual event where we join together to celebrate the work of our Department, and this year we made the most of being able to meet up in person, in a new venue, and with an innovative programme.
New programme to move potential MND drugs into clinical trials faster
21 June 2023
A ground-breaking experimental medicine programme that will enable researchers to more rapidly screen potential drugs in people with motor neuron disease (MND, also known as ALS), is announced today on Global MND Awareness Day.
Beacon Therapeutics launched to develop new generation of gene therapies for retinal diseases
12 June 2023
Beacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive £96 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.
University of Oxford and Selvita collaborate to advance potential therapeutics for Parkinson's Disease
26 May 2023
The University of Oxford and Selvita (WSE: SLV), one of the largest contract research organisations in Europe, are collaborating on drug discovery in the area of Parkinson's disease
Colin Espie becomes a Fellow of the Academy of Medical Sciences
18 May 2023
Professor Espie is one of eight Oxford researchers to become Fellows of the Academy of Medical Sciences.